Clinical Trial Update: ZOSTAVAX® in Renal Transplant Patients [Phase 1]

View source ↗

Summary

Phase 1 trial of ZOSTAVAX in renal transplant patients has completed, evaluating herpes zoster prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Zostavax (Varicella zoster vaccine live)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Herpes Zoster | Phase 1 | Status: COMPLETED